DIN 02375842 — ONGLYZA 2.5 MG
ONGLYZA is a tablet of Saxagliptin marketed by ASTRAZENECA CANADA INC. The full Saxagliptin monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02375842
- Brand name
- ONGLYZA
- Active ingredient
- Saxagliptin
- Strength
- 2.5 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- ASTRAZENECA CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Dipeptidyl peptidase-4 (DPP-4) inhibitor (oral antihyperglycemic agent)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Saxagliptin products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02507471 | APO-SAXAGLIPTIN | 2.5 MG | TABLET | APOTEX INC | MARKETED |
| 02507498 | APO-SAXAGLIPTIN | 5 MG | TABLET | APOTEX INC | MARKETED |
| 02333554 | ONGLYZA | 5 MG | TABLET | ASTRAZENECA CANADA INC | MARKETED |
| 02468603 | SANDOZ SAXAGLIPTIN | 2.5 MG | TABLET | SANDOZ CANADA INCORPORATED | MARKETED |
| 02468611 | SANDOZ SAXAGLIPTIN | 5 MG | TABLET | SANDOZ CANADA INCORPORATED | MARKETED |